Saturday, August 16th 2025, 10:07 am
Lower back pain is one of the most common health conditions worldwide, affecting an estimated 619 million people. In the United States, more than 1.2 million spinal surgeries are performed each year, but many patients continue to experience discomfort.
This recurring pain, known as failed back surgery syndrome, affects between 10 and 40 percent of those who undergo traditional procedures.
A new option, basal vertebral nerve ablation, is emerging as a targeted treatment for patients with vertebrogenic pain—pain caused by nerves inside the spinal bones themselves. The procedure uses a radio frequency probe to deactivate the nerves within the vertebrae that transmit pain signals from the disc and end plates.
The treated nerves typically do not regenerate for at least five years, offering the possibility of long-lasting or even permanent pain relief.
Roughly 30 million Americans live with chronic back pain, but only about one in six are thought to have vertebrogenic pain, which means not all patients are eligible. The procedure is not recommended for pain that is likely to resolve on its own.
Age is not considered a barrier to the treatment, and recovery involves few restrictions. Patients are advised to limit lifting for up to 12 weeks to protect bone health following the surgery.
August 16th, 2025
August 16th, 2025
August 16th, 2025
August 16th, 2025
August 16th, 2025
August 16th, 2025